scholarly article | Q13442814 |
P356 | DOI | 10.1093/JAC/DKS435 |
P698 | PubMed publication ID | 23111850 |
P50 | author | Maree Smith | Q24851696 |
Jason A. Roberts | Q38544404 | ||
Kiran Shekar | Q58396529 | ||
Steven C Wallis | Q58397119 | ||
P2093 | author name string | John F Fraser | |
Daniel V Mullany | |||
Sussan Ghassabian | |||
P2860 | cites work | Meropenem dosing in critically ill patients with sepsis receiving high-volume continuous venovenous hemofiltration | Q24620193 |
Pharmacokinetics in the newborn | Q35111481 | ||
Sequestration of drugs in the circuit may lead to therapeutic failure during extracorporeal membrane oxygenation | Q36928231 | ||
Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients | Q39487652 | ||
Determinants of drug absorption in different ECMO circuits. | Q42362818 | ||
Therapeutic drug monitoring of beta-lactams in critically ill patients: proof of concept | Q42946682 | ||
Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution. | Q46034494 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | pharmacokinetics | Q323936 |
extracorporeal membrane oxygenation | Q1385195 | ||
P1104 | number of pages | 2 | |
P304 | page(s) | 726-727 | |
P577 | publication date | 2012-10-30 | |
P1433 | published in | Journal of Antimicrobial Chemotherapy | Q6294770 |
P1476 | title | Altered antibiotic pharmacokinetics during extracorporeal membrane oxygenation: cause for concern? | |
P478 | volume | 68 |
Q34494688 | ASAP ECMO: Antibiotic, Sedative and Analgesic Pharmacokinetics during Extracorporeal Membrane Oxygenation: a multi-centre study to optimise drug therapy during ECMO. |
Q41554621 | Alveolar and serum concentrations of imipenem in two lung transplant recipients supported with extracorporeal membrane oxygenation |
Q33821972 | Antibiotic dosing in critically ill patients with septic shock and on continuous renal replacement therapy: can we resolve this problem with pharmacokinetic studies and dosing guidelines? |
Q51581871 | Azithromycin Pharmacokinetics in Adults With Acute Respiratory Distress Syndrome Undergoing Treatment With Extracorporeal-Membrane Oxygenation. |
Q90267103 | Drug Disposition and Pharmacotherapy in Neonatal ECMO: From Fragmented Data to Integrated Knowledge |
Q55145216 | Drugs pharmacokinetics during veno-venous extracorporeal membrane oxygenation in pediatrics. |
Q39188586 | Medicating patients during extracorporeal membrane oxygenation: the evidence is building |
Q30811829 | Optimal management of the critically ill: anaesthesia, monitoring, data capture, and point-of-care technological practices in ovine models of critical care |
Q47632337 | Pharmacokinetic changes of antibiotic, antiviral, antituberculosis and antifungal agents during extracorporeal membrane oxygenation in critically ill adult patients. |
Q88271342 | Pharmacokinetic/Pharmacodynamic Considerations of Beta-Lactam Antibiotics in Adult Critically Ill Patients |
Q51702479 | Pharmacokinetics of continuous-infusion meropenem in a pediatric patient receiving extracorporeal life support. |
Q30249512 | Pharmacotherapy during pediatric extracorporeal membrane oxygenation: a review |
Q54257517 | Population Pharmacokinetics of Meropenem in Plasma and Subcutis from Patients on Extracorporeal Membrane Oxygenation Treatment. |
Q41052029 | Propofol, midazolam, vancomycin and cyclosporine therapeutic drug monitoring in extracorporeal membrane oxygenation circuits primed with whole human blood |
Q36928231 | Sequestration of drugs in the circuit may lead to therapeutic failure during extracorporeal membrane oxygenation |
Q40223593 | Successful use of extracorporeal membrane oxygenation in a human immunodeficiency virus infected patient with severe acute respiratory distress syndrome |
Q34630847 | The ECMO PK Project: an incremental research approach to advance understanding of the pharmacokinetic alterations and improve patient outcomes during extracorporeal membrane oxygenation |
Q34996307 | The combined effects of extracorporeal membrane oxygenation and renal replacement therapy on meropenem pharmacokinetics: a matched cohort study |
Search more.